Pre-Travel Medical Preparation of Business and Occupational Travelers

Journal of Occupational and Environmental Medicine

Volumn 58, Issue 1, 2016, Pages 76-82

  Khan, Nomana M ^a   Jentes, Emily S ^a   Brown, Clive ^a   Han, Pauline ^a   Rao, Sowmya R ^b,c   Kozarsky, Phyllis ^a   Hagmann, Stefan H F ^d,e   LaRocque, Regina C ^f   Ryan, Edward T ^f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BRONX LEBANON HOSPITAL CENTER   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; ANTIMALARIAL AGENT; VACCINE;

ADULT; AGED; ARTICLE; COMMERCIAL PHENOMENA; CONSULTATION; DEMOGRAPHY; EMPLOYER; EMPORIATRICS; FEMALE; HEPATITIS B; HUMAN; IMMUNITY; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; ADOLESCENT; INTERNATIONAL COOPERATION; LEISURE; MIDDLE AGED; OCCUPATIONAL HEALTH; PATIENT REFERRAL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TRAVEL; TREATMENT REFUSAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; COMMERCE; FEMALE; HUMANS; LEISURE ACTIVITIES; MALE; MEDICAL MISSIONS, OFFICIAL; MIDDLE AGED; OCCUPATIONAL HEALTH; REFERRAL AND CONSULTATION; TIME FACTORS; TRAVEL; TREATMENT REFUSAL; VACCINES; YOUNG ADULT;

EID: 84958006526     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000602     Document Type: Article

References (31)

1. United Nations World Tourism Organization. Tourism Highlights 2012. Available at: http://dtxtq4w60xqpw.cloudfront.net/sites/all/files/pdf/unwto-Annual-report-2014.pdf. Accessed September 3, 2015.
2. Office of travel and tourism industries. Profile of US resident travelers visiting overseas destinations: outbound 2012. Available at: http://travel.Trade.gov/outreachpages/download-data-Table/2012-Outbound-Profile.pdf. Accessed April 22, 2015.
3. CDC. Available at: http://wwwnc.cdc.gov/travel/page/business. Accessed April 22, 2015.
4. Aw J, Band AR. The Corporate and Executive Traveler. Book Chapter 29, Section 6 (3rd Edition). Elsevier Inc; 2012: 283-89.
5. Concur Expense IQ Report. Available at: https://www.concur.com/sites/default/files/2013-concur-expenseiq-report.pdf. Accessed: April 22, 2015.
6. Patel D. Occupational travel. Occup Med (Lond). 2011;61:6-18.
7. Leder K, Chen LH, Wilson ME. Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis. Vaccine. 2012;30:2600-2604.
8. LaRocque RC, Rao SR, Lee J, et al. Global TravEpiNet: A national consortium of clinics providing care to international travelers-Analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis. 2012;54:455-462.
9. Centers for Disease Control and Prevention. Yellow Book: CDC Health Information for International Travel 2010. Atlanta: US. Departent of Health and Human Services, Public Health Service; 2009.
10. Centers for Disease Control and Prevention. Yellow Book: CDC Health Information for International Travel 2012. New York: Oxford University Press; 2012.
11. Stoney RJ, Jentes ES, Sotir MJ, et al. Pre-Travel preparation of US travelers going abroad to provide humanitarian service, Global TravEpiNet 2009-2011. Am J Trop Med Hyg. 2014;90:553-559.
12. Indices & Data. Human Development Reports (HDR). United Nations Development Programme (UNDP) [Internet]. Available at: http://hdr.undp. org/en/statistics/. Accessed April 22, 2015.
13. Rao SR, LaRocque RC, Jentes ES, et al. Comparison of methods for clustered data analysis in a non-ideal situation: results from an evaluation of predictors of yellow fever vaccine refusal in the Global TravEpiNet (GTEN) Consortium. Int J Stat Med Res. 2014;3:215-223.
14. Hill DR. Pre-Travel health, immunization status, and demographics of travel to the developing world for individuals visiting a travel medicine service. Am J Trop Med Hyg. 1991;45:263-270.
15. Pavli A, Silvestros C, Patrinos S, Lymperi I, Maltezou HC. Pre-Travel preparation practices among business travellers to tropical and subtropical destinations: results from the Athens International Airport Survey. Travel Med Infect Dis. 2014;12:364-369.
16. Weber R, Schlagenhauf P, Amsler L, Steffen R. Knowledge, attitudes and practices of business travelers regarding malaria risk and prevention. J Travel Med. 2003;10:219-224.
17. Chen LH, Leder K, Wilson ME. Business travelers: vaccination considerations for this population. Expert Rev Vaccines. 2013;12:453-466.
18. van Genderen PJ, van Thiel PP, Mulder PG, Overbosch D, Dutch Schiphol Airport Study Group. Trends in knowledge, attitudes, and practices of travel risk groups toward prevention of hepatitis A: results from the Dutch Schiphol Airport survey 2002 to 2009. J Travel Med. 2012;19: 35-43.
19. Correia JD, Shafer RT, Patel V, et al. Blood and body fluid exposure as a health risk for international travelers. J Travel Med. 2001;8:263-266.
20. Foster SL, Nevin-Woods CR. Revisiting the influenza vaccine. J Am Osteopath Assoc. 2011;111(suppl 6):S2-S4.
21. Centers for Disease Control and Prevention. Interim results: state-specific influenza vaccination coverage-United States, August 2010-February 2011. MMWR Morb Mortal Wkly Rep. 2011;60:737-743.
22. Boggild AK, Castelli F, Gautret P, et al. Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network. Vaccine. 2010;28:7389-7395.
23. Helfenberger S, Tschopp A, Robyn L, Hatz C, Schlagenhauf P. Knowledge, attitudes, and practices of business travelers regarding influenza and the use of antiviral medication. J Travel Med. 2010;17:367-373.
24. Hudson TW, Fortuna J. Overview of selected infectious disease risks for the corporate traveler. J Occup Environ Med. 2008;50:924-934.
25. Liese B, Mundt KA, Dell LD, Nagy L, Demure B. Medical insurance claims associated with international business travel. Occup Environ Med. 1997;54:499-503.
26. Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS) and coronavirus testing: United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:297-302.
27. Bunn 3rd WB. Risk and burden associated with the acquisition of viral hepatitis A and B in the corporate traveler. J Occup Environ Med. 2008;50:935-944.
28. Lim PL, Han P, Chen LH, et al. Expatriates ill after travel: results from the Geosentinel Surveillance Network. BMC Infect Dis. 2012;12:386.
29. NPR News. Measles outbreak shows even vaccinated at risk. Available at: http://www.npr.org/templates/story/story.php?storyIdU5500100. Accessed June 2, 2015.
30. The Boston Globe. Measles outbreak shows a global threat-Worker from India tied to Hub cases. Available at: http://www.boston.com/yourlife/health/diseases/articles/2006/06/10/measles-outbreak-shows-A-global-Threat/?pageUfull. Accessed June 2, 2015.
31. Bunn W. Vaccine and international health programs for employees traveling and living abroad. J Travel Med. 2001;8(suppl 1):S20-S23.